CN112695006A - Recombinant bacillus subtilis for expressing D-psicose-3-epimerase - Google Patents

Recombinant bacillus subtilis for expressing D-psicose-3-epimerase Download PDF

Info

Publication number
CN112695006A
CN112695006A CN202110163604.8A CN202110163604A CN112695006A CN 112695006 A CN112695006 A CN 112695006A CN 202110163604 A CN202110163604 A CN 202110163604A CN 112695006 A CN112695006 A CN 112695006A
Authority
CN
China
Prior art keywords
psicose
bacillus subtilis
pma5
recombinant
epimerase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110163604.8A
Other languages
Chinese (zh)
Other versions
CN112695006B (en
Inventor
饶志明
魏玉霞
张显
胡孟凯
杨套伟
徐美娟
邵明龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202110163604.8A priority Critical patent/CN112695006B/en
Publication of CN112695006A publication Critical patent/CN112695006A/en
Application granted granted Critical
Publication of CN112695006B publication Critical patent/CN112695006B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y501/00Racemaces and epimerases (5.1)
    • C12Y501/03Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a recombinant bacillus subtilis for expressing D-psicose-3-epimerase, belonging to the technical field of bioengineering. The D-psicose 3-epimerase is obtained from Dorea sp.CAG317 and Clostridium cellulolyticum H10, and the recombinant Bacillus subtilis is constructed by taking Bacillus subtilis 168 as a chassis cell and pMA5 as an expression vector, so that the expression of the D-psicose 3-epimerase is realized. Through screening of a strong constitutive promoter, the catalytic efficiency of the recombinant strain is successfully improved to 12-13 times that of a single-enzyme recombinant strain under a weak acid condition, the recombinant strain B.subtilis 168/pMA5-spovG-DS-srfA-RC can generate 244.3g/L of D-psicose within 30 minutes, the conversion rate is 32.6%, and the browning phenomenon of a reaction solution is eliminated.

Description

Recombinant bacillus subtilis for expressing D-psicose-3-epimerase
Technical Field
The invention relates to recombinant bacillus subtilis for expressing D-psicose-3-epimerase, and belongs to the technical field of bioengineering.
Background
D-psicose (D-allulose) is an epimer of D-fructose at the C3 position, has a melting point of 96 ℃, and has high solubility in water: 291g of D-psicose can be dissolved in 100g of water at 25 ℃, the mass percent is 74% (w/w), and the solution density reaches 1.35 kg/L; the solubility is further increased at 50 ℃, 489g of D-psicose can be dissolved in each 100g of water, and the mass percent is 83% (w/w). D-psicose is a novel functional monosaccharide with special health care function discovered in recent years, the sweetness of the D-psicose is equal to 70% of that of cane sugar, the calorie of the D-psicose is equal to 0.3% of that of cane sugar, the D-psicose has similar taste and volume characteristics with the cane sugar, and the D-psicose can also generate Maillard reaction with amino acid or protein in food and can be used as an ideal substitute of the cane sugar in food. Toxicological experiments confirmed that D-psicose has a median Lethal Dose (LD)50) 16.3g/kg, LD compared to fructose5014.7g/kg, LD of erythritol50At 15.3g/kg, D-psicose belongs to the "relatively harmless" category (lowest toxicity rating) according to toxicity rating. In 2014, D-psicose was officially approved by the U.S. Food and Drug Administration (FDA) as Generally Recognized As Safe (GRAS) allowing its application in food, dietary supplements, and pharmaceutical preparations.
D-psicose has various health-care effects, and can be used for resisting hyperglycemia, preventing or treating obesity and inflammation caused by obesity, advantageously regulating cholesterol metabolism, and exerting its biological effect by regulating intestinal microbiota. At a maximum dose of 2000mg/kg, D-psicose had no adverse effect on reproductive toxicity in rats. D-psicose belongs to a rare sugar in the natural world and can be synthesized by a chemical method and a microbiological method. Because the chemical method is not friendly to the environment, the biological method for synthesizing the D-psicose is widely concerned about the environmental protection; the biological method is generally used for preparing D-psicose under the catalysis of D-psicose 3-epimerase or D-tagatose 3-epimerase, but non-enzymatic browning is easy to occur in the preparation process, and is also called Maillard reaction.
Maillard reactions can affect the manufacture and storage of many food products and can occur in almost all food products, including the scorching effects of sugars and other carbohydrates, and maillard reactions that occur after carbohydrates, proteins, amino acids, etc. have been heat treated or stored, and both chemical reactions can produce a brownish color. Although some foods are intentionally prepared by utilizing the color produced by the Maillard reaction, the Maillard reaction in the case of D-psicose preparation by biotransformation consumes sugars to produce by-products and blackens the color of the product, thus burdening downstream purification processes.
In addition, in the prior art, the D-psicose 3-epimerase is an enzyme which can keep higher enzyme activity under an alkaline condition, and the enzyme activity is insufficient under a weak acid condition; in the previous studies, the inventors compared the activities of D-psicose 3-epimerase DPEase derived from Dorea sp.CAG317 and Clostridium cellulolyticum H10D-psicose 3-epimerase RCDPEase under different pH conditions, and the results are shown in Table 1:
table 1: enzyme activities of different D-psicose 3-epimerases under different pH conditions
pH Relative enzyme activity of DSDPEase (%) Relative enzyme activity of RCDPEase (%)
4.5 acetic acid/sodium acetate 0 3.24
5 acetic acid/sodium acetate 12.30902 11.27
5.5 acetic acid/sodium acetate 29.71851 35.86
6 acetic acid/sodium acetate 56.23458 48
6 disodium hydrogen phosphate/sodium dihydrogen phosphate 20.92 25.7
6.5 disodium hydrogen phosphate/sodium dihydrogen phosphate 31.51 34.24
7 disodium hydrogen phosphate/sodium dihydrogen phosphate 56.36 41.23
7.5 disodium hydrogen phosphate/sodium dihydrogen phosphate 71.78 39.93
7.5 Tris/HCl 73.06 51.63
8 Tris/hydrochloric acid 82.39 49.93
8.5 Tris/HCl 100 100
9 Tris/hydrochloric acid 89.99 86.43
As can be seen, the enzyme activity of the D-psicose 3-epimerase is low at pH 6-7, while in many industrial reactions, pH 6-7 is a common reaction condition, and the enzyme activity of the D-psicose 3-epimerase is low at this time, so how to improve the enzyme activity of the D-psicose 3-epimerase under weak acid conditions becomes a hot point of research.
The bacillus subtilis is a GRAS strain approved by FDA, has clear genetic background and good operability and safety, and is an important industrial production strain. The Bacillus subtilis expression elements are rich, have great mining potential, have various endogenous strong constitutive promoters and self-inducible promoters, and do not need to add additional substances in the culture process to induce protein expression.
Therefore, how to successfully express the D-psicose 3-epimerase by using the bacillus subtilis, weaken the Maillard reaction between a sugar solution and a biological enzyme in a catalytic reaction, and keep higher enzyme activity under a weak acid condition is a difficult problem in industrial production.
Disclosure of Invention
The technical problem is as follows:
the technical problem to be solved by the invention is to provide the recombinant bacillus subtilis of the D-psicose 3-epimerase which can successfully express and weaken the Maillard effect in the reaction process and can keep higher enzyme activity under the weak acid condition and the application thereof.
The technical scheme is as follows:
the D-psicose 3-epimerase genes (DSDPEase and RCDPEase) of a source Dorea sp.CAG317 and Clostridium cellulolyticum H10 are co-expressed in the bacillus subtilis 168; the promoter HpaII, the promoter P43, the promoter srfA and the promoter spovG are respectively inserted into the end of a gene segment DSDPEase5 'and the end of a gene segment RCDPEase 5' by constructing an expression system B.subtilis 168/pMA5-DS-RC, and the recombinant bacteria are expressed under corresponding culture conditions.
In order to solve the above problems, the present invention provides a recombinant Bacillus subtilis expressing D-psicose 3-epimerase derived from Dorea sp.CAG317 and D-psicose 3-epimerase derived from Clostridium cellulolyticum H10.
In one embodiment of the present invention, the recombinant Bacillus subtilis is Bacillus subtilis 168 as an expression host.
In one embodiment of the present invention, the recombinant bacillus subtilis is a pMA5 expression vector.
In one embodiment of the invention, the recombinant Bacillus subtilis is one that enhances the expression of D-psicose 3-epimerase using one or more of the promoters HpaII, P43, srfA, spovG.
In one embodiment of the invention, the promoters HpaII, P43, srfA and spovG are inserted into the ends of the gene segment DSDPEase5 'and the gene segment RCDPEase 5', respectively, and the recombinant bacteria are expressed under corresponding culture conditions.
In one embodiment of the invention, the amino acid sequence of the D-psicose 3-epimerase derived from Dorea sp.CAG317 is shown in SEQ ID NO 1, and the amino acid sequence of the D-psicose 3-epimerase derived from Clostridium cellulolyticum H10 is shown in SEQ ID NO 2.
In one embodiment of the invention, the nucleotide sequence of the gene encoding D-psicose 3-epimerase derived from Dorea sp.CAG317 is shown in SEQ ID NO 7, and the nucleotide sequence of the gene encoding D-psicose 3-epimerase derived from Clostridium cellulolyticum H10 is shown in SEQ ID NO 8.
In one embodiment of the invention, the nucleotide sequence of the promoter HpaII is shown as SEQ ID NO 3; the nucleotide sequence of the promoter P43 is shown as SEQ ID NO 4; the nucleotide sequence of the promoter srfA is shown as SEQ ID NO 5; the nucleotide sequence of the promoter spovG is shown as SEQ ID NO 6.
The invention also provides a method for constructing the recombinant bacillus subtilis, which comprises the following steps:
(1) constructing a recombinant plasmid: respectively carrying out enzyme digestion on D-psicose 3-epimerase DS derived from Dorea sp.CAG317 and D-psicose 3-epimerase RC derived from Clostridium cellulolyticum H10 and a pMA5 plasmid, and then connecting to obtain a recombinant plasmid pMA 5-DS-RC;
(2) constructing recombinant bacillus subtilis: and (2) transforming the recombinant plasmid pMA5-DS-RC obtained in the step (1) into the bacillus subtilis 168 to obtain the recombinant bacillus subtilis.
The invention also provides a method for weakening browning reaction, which is to add the recombinant bacillus subtilis into a reaction system containing D-fructose for reaction.
In one embodiment of the present invention, OD of the recombinant Bacillus subtilis is added600At least 15.
In one embodiment of the invention, the reaction is carried out at a pH of 6.0 to 7.0 and a temperature of 55 to 65 ℃.
The invention also provides application of the recombinant bacillus subtilis in weakening browning reaction in food or application in preparing high-sweetness low-calorie food.
The invention also provides the recombinant bacillus subtilis with improved enzyme activity under acidic conditions, and the Maillard reaction browning phenomenon in the D-psicose biotransformation process is weakened.
Advantageous effects
(1) The recombinant strains B.subtilis 168/pMA5-DS-RC, B.subtilis 168/pMA5-DS-srfA-RC, B.subtilis 168/pMA5-DS-HpaII-RC, B.subtilis 168/pMA5-DS-P43-RC, B.subtilis 168/pMA5-DS-srfA-RC, B.subtilis 168/pMA 567-DS-spovG-RC, B.subtilis 168/pMA5-P43-DS-srfA-RC, B.subtilis 168/pMA 5-DS-srfG-RC are constructed by successfully introducing D-psicose 3-epimerase genes (DSDPEase and RCDPEase) from Dorea sp 317 and Clostridium cellulolyticum H10 and co-expressing the recombinant strains.
(2) The recombinant strain B.subtilis 168/pMA5-spovG-DS-srfA-RC with the highest whole-cell enzyme activity obtained by the method is reacted under the condition of pH6.5 without browning, the enzyme activity is improved by 12-13 times compared with that of a single enzyme expression strain, the enzyme activity is still more than 50 percent by repeatedly utilizing batches of 13 times, and the problem of insufficient enzyme activity under the weak acid condition is solved.
(3) The method provided by the invention can prevent the Maillard reaction from releasing melanin under the weak acidic condition. Recombinant strain b.subtilis 168/pMA5-spovG-DS-srfA-RC produced 244.3g/L of D-psicose in 30 minutes with a conversion of 32.6% under weak acid (pH 6.5) at a substrate fructose concentration of 750 g/L.
Drawings
FIG. 1: SDS-PAGE gel electrophoresis of the crude enzyme solution; wherein, lane 1: subtilis 168/pMA5 empty control; lane 2: supernatants of subtilis 168/pMA 5-DS; lane 3: subtilis 168/pMA5-RC supernatant; lane 4: subtilis 168/pMA5-DS-RC supernatant; lane 5: sublis 168/pMA5-DS-HpaII-RC supernatant; lane 6: a supernatant of subtilis 168/pMA 5-DS-P43-RC; lane 7: subtilis 168/pMA5-DS-srfA-RC supernatant; lane 8: sublis 168/pMA5-DS-spovG-RC supernatant.
FIG. 2: SDS-PAGE gel electrophoresis of the crude enzyme solution; subtilis 168/pMA5 empty control; lane 2: subtilis 168/pMA5-DS-srfA-RC supernatant; lane 3: sublis 168/pMA5-spovG-DS-srfA-RC supernatant; lane 4: sublis 168/pMA5-P43-DS-srfA-RC supernatant.
FIG. 3: influence of different pH values on browning of the reaction solution.
FIG. 4: the biomass and specific enzyme activity in the continuous fermentation process are changed.
Detailed Description
The media involved in the following examples are as follows:
LB liquid medium: 10g/L of peptone, 10g/L of sodium chloride and 5g/L of yeast powder.
LB solid medium: 10g/L of peptone, 10g/L of sodium chloride, 5g/L of yeast powder and 20g/L of agar powder.
Super Rich medium: 25g/L of peptone, 20g/L of yeast powder, 3g/L of dipotassium hydrogen phosphate and 30g/L of glucose.
Seed culture medium: 15g/L of sucrose and 20g/L, Na of yeast extract powder2HPO4·12H2O 1g/L、Mn2+0.05mmol/L and 8g/L of sodium chloride.
Fermentation medium: 15g/L of sucrose, 20g/L of yeast powder, 4g/L of sodium dihydrogen phosphate, 1g/L of sodium dihydrogen phosphate and 8g/L of sodium chloride.
The detection methods referred to in the following examples are as follows:
the enzyme activity determination method of the D-psicose enzyme comprises the following steps:
(1) determination of pure enzyme activity
Collecting cells, and treating the cells with pH 7.050 mmol. multidot.L-1Na2HPO4-NaH2PO4Suspending with buffer solution, centrifuging, washing for 3 times, resuspending cells, adding lysozyme with final concentration of 1mg/mL, acting for a period of time, ultrasonically breaking cells, and centrifuging to obtain supernatant, i.e. crude enzyme solution. The DPEase pure enzyme is obtained by Ni column affinity chromatography purification and is used for detecting the activity of the pure enzyme. Enzyme activity assay reaction system (total system 1 mL): 900 μ L of pH 8.550 mmol. multidot.L-1Na2HPO4-NaH2PO4Buffer-dissolved 100mg D-fructose and 2. mu.L 70mM Co2+Preheating the solution in 60 deg.C water bath for 5min, adding 100 μ L pure enzyme, and directly adding 100 μ L50 mmol/L for contrast reaction-1Na2HPO4-NaH2PO4And (3) reacting the buffer solution in a constant-temperature water bath at 60 ℃ for 30min, and quickly terminating the reaction in a boiling water bath.Placing the enzyme reaction solution into a centrifuge at 10000 r.min-1Centrifuging for 10min under the condition of (1), removing protein, precipitating, collecting supernatant, and diluting the product concentration of the reaction solution to 5 g.L-1And taking 1mL of reaction solution to perform high performance liquid chromatography determination analysis.
(2) Crude enzyme activity assay
Measuring the activity of the crude enzyme liquid, reacting in a 2mL EP tube, wherein the reaction system is 1mL, the D-fructose content is 300g/L, the reaction temperature is 60 ℃, and 900 mu L of NaH is added2PO4/Na2HPO4 buffer,Co2+Reacting 100 μ L of crude enzyme solution with final concentration of 140 μmol/L in a metal oscillator for 2min, immediately taking out, putting into boiling water, boiling for 5min to terminate the reaction, centrifuging at 1200rpm to separate protein precipitate from D-fructose and D-psicose solution, putting the supernatant into a refrigerator at-40 deg.C, and storing.
The product analysis method was consistent with that of pure enzyme.
(3) Whole cell enzyme activity assay
Measuring the activity of the whole cell enzyme, centrifuging 1mL of bacterial liquid, and using NaH with pH 7.02PO4/Na2HPO4buffer 3 times, suspend in 100. mu.L NaH2PO4/Na2HPO4To the buffer, 900. mu.L of 300g/L D-fructose solution was added. Reacting for 5min in a metal shaking period, immediately taking out to 4 ℃ refrigerated centrifuge, centrifuging at 12000rpm for 2min, taking supernatant, placing in a refrigerator at-40 ℃ and preserving, wherein the enzyme activity definition is consistent with that of the crude enzyme solution. The product analysis method was consistent with that of pure enzyme.
50mM Na2HPO4-NaH2PO4(pH 6.5, 7.0 or 8.5) buffer: 7.098g of Na were weighed2HPO4Dissolving in distilled water, and diluting to 1L; 5.999g NaH were weighed2PO4Dissolving in distilled water, and diluting to 1L; the two buffers were mixed to adjust the pH.
Reaction substrate solution (100g/L D-fructose): 10g D-fructose was weighed out and dissolved in 50mM Na pH 8.52HPO4-NaH2PO4The volume of the buffer solution is 100mL, and the solution is stored in a refrigerator at 4 ℃. HPLC detection conditions: RID detector, mobile phase ultrapure water, chromatographic column Hi-Plex Ca30X 7.7mm, column temperature 80 ℃, detection temperature 55 ℃ and flow rate 0.4 mL/min.
D-psicose 3-epimerase enzyme activity unit: the amount of enzyme required to catalyze the formation of 1. mu. mol of D-psicose within 1min was defined as one unit of enzyme activity.
D-psicose 3-epimerase specific enzyme activity: one unit of enzyme activity is defined as the amount of enzyme required to catalyze the formation of 1. mu. mol D-psicose per minute under the assay conditions.
Equilibrium conversion: means that when the reversible chemical reaction of converting D-fructose into D-psicose reaches a chemical equilibrium state, the amount of D-fructose converted into D-psicose is a percentage of the initial amount of D-fructose.
Example 1: obtaining of recombinant plasmid
(1) A gene DSDPEase which has a nucleotide sequence shown as SEQ ID NO 7 and codes D-psicose 3-epimerase and a gene RCDPEase which has a nucleotide sequence shown as SEQ ID NO 8 and codes D-psicose 3-epimerase are synthesized chemically.
(2) Designing primers required by fusion PCR of promoter HpaII (nucleotide sequence is shown as SEQ ID NO 3), P43 (nucleotide sequence is shown as SEQ ID NO 4), srfA (nucleotide sequence is shown as SEQ ID NO 5) and spovG (nucleotide sequence is shown as SEQ ID NO 6) fragments, DSDPEase and RCDPEase gene fragments, wherein the sequences of the used primers are shown as table 2, and cloning different promoter fragments by taking a bacillus subtilis genome as a gene template.
TABLE 2 primer sequences
Figure BDA0002936580250000061
Figure BDA0002936580250000071
(3) And (3) PCR reaction conditions: the two segments are fused under PCR conditions, 30S at 58 ℃ and 90S at 72 ℃ and are circulated for 8 times; after the primer is added, continuing PCR at 95 ℃ for 3 min; circulating for 32 times at 95 ℃ for 30S, 58 ℃ for 30S and 72 ℃ for 2 min; 10min at 72 ℃; keeping the temperature permanently at 4 ℃.
pMA5 plasmid reverse PCR, design primer pMA5-F ', pMA5-R', use pMA5 empty as template, PCR program is 95 degrees C3 min; circulating for 32 times at 95 ℃ for 30S, 58 ℃ for 30S and 72 ℃ for 7 min; 10min at 72 ℃; keeping the temperature permanently at 4 ℃.
(4) Purification and recovery of PCR amplified products
The PCR amplification products were spotted on a nucleic acid gel agarose gel electrophoresis to view the position of the bands. The desired gel pieces were excised and the target gene was purified strictly according to the instructions of the kit for recovery of nucleic acid gel.
Through fusion PCR, after a Promoter gene fragment and a DPEase gene fragment are fused together in the first step, fusion products obtained in the first step are added into a system for the second step of fusion to obtain a Promoter1-DSDPEase-Promoter2-RCDPEase gene fragment, and fusion PCR is carried out on different Promoter combinations by the method to prepare for constructing recombinant plasmids in the next step.
(5) Construction of recombinant plasmid
Carrying out plasmid extraction according to a plasmid extraction kit GENERAY biotechnology, carrying out double enzyme digestion on an expression vector pMA5, carrying out nucleic acid gel verification on a product obtained after enzyme digestion, recovering and purifying, and carrying out a recovery step according to the instructions of a gel recovery kit.
The target gene fragment is connected with the linearized plasmid after enzyme digestion by using homologous recombinase to respectively obtain recombinant plasmids pMA5-DS, pMA5-RC, pMA5-DS-RC, pMA5-DS-HpaII-RC, pMA5-DS-srfA-RC, pMA5-DS-P43-RC, pMA5-DS-spovG-RC, pMA5-P43-DS-srfA-RC and pMA 5-spovG-DS-srfA-RC.
Example 2: construction and expression of recombinant bacteria
The method comprises the following specific steps:
(1) construction of the amplified strains:
the recombinant plasmids pMA5-DS, pMA5-RC, pMA5-DS-RC, pMA5-DS-HpaII-RC, pMA5-DS-srfA-RC, pMA5-DS-P43-RC, pMA5-DS-spovG-RC, pMA5-P43-DS-srfA-RC, pMA5-spovG-DS-srfA-RC obtained in example 1 were introduced into E.coli JM109 for plasmid amplification by chemical transformation, and inoculated to 10mL of solid LBIn the culture medium, the temperature is 37 ℃, and the temperature is 180 r.min-1Culturing for 10h, and extracting plasmids respectively according to the bacterial plasmid extraction kit.
(2) Constructing a recombinant strain:
respectively introducing the amplified plasmids obtained in the step (1) into bacillus subtilis 168 in a chemical conversion mode, respectively inoculating the obtained recombinant strains into 10mL of LB solid culture medium after colony PCR verification, and respectively inoculating at 37 ℃ for 180 r.min-1Culturing for 10h under the condition to obtain recombinant strains B.subtilis 168/pMA5-DS, B.subtilis 168/pMA5-RC, B.subtilis 168/pMA5-DS-RC, B.subtilis 168/pMA5-DS-HpaII-RC, B.subtilis 168/pMA5-DS-srfA-RC, B.subtilis 168/pMA5-DS-P43-RC, B.subtilis 168/pMA5-DS-spovG-RC, B.subtilis 168/pMA5-P43-DS-srfA-RC, B.subtilis 168/pMA5-spovG-DS-srfA-RC and strain preservation at-80 ℃.
(3) Expression and enzyme activity determination of the recombinant bacteria:
respectively transferring the bacillus subtilis recombinant strains obtained in the step (2) to 10mL LB liquid culture medium, and culturing at 37 ℃ for 180 r.min-1Culturing for 10h under the condition to respectively obtain seed solutions containing the recombinant strains.
The seed solutions obtained above were each transferred to 100mL of Super Rich medium at an inoculum size of 1% (v/v), and the mixture was incubated at 37 ℃ for 180 r.min-1Culturing for 24h under the condition, expressing the D-psicose 3-epimerase to respectively obtain crude enzyme liquid containing the D-psicose 3-epimerase, and obtaining the following products: a DS-RC-containing crude enzyme solution, a DS-containing crude enzyme solution, an RC-containing crude enzyme solution, a DS-HpaII-RC-containing crude enzyme solution, a DS-P43-RC-containing crude enzyme solution, a DS-srfA-RC-containing crude enzyme solution, a pMA 5-DS-spovG-RC-containing crude enzyme solution, a P43-DS-srfA-RC-containing crude enzyme solution, and a spovG-DS-srfA-RC-containing crude enzyme solution.
The obtained DS-RC-containing crude enzyme solution, DS-RC-containing crude enzyme solution, DS-HpaII-RC-containing crude enzyme solution, DS-P43-RC-containing crude enzyme solution, DS-srfA-RC-containing crude enzyme solution, pMA 5-DS-spovG-RC-containing crude enzyme solution, P43-DS-srfA-RC-containing crude enzyme solution, and spovG-DS-srfA-RC-containing crude enzyme solution were subjected to SDS-PAGE gel electrophoresis analysis, and the results of the analysis are shown in FIGS. 1 and 2.
As can be seen from FIGS. 1 and 2, the recombinant strains B.subtilis 168/pMA5-DS-RC, B.subtilis 168/pMA5-DS-HpaII-RC, B.subtilis 168/pMA5-DS-P43-RC, B.subtilis 168/pMA5-DS-srfA-RC, B.subtilis 168/pMA5-DS-spovG-RC, B.subtilis 168/pMA5-P43-DS-srfA-RC, and B.subtilis 168/pMA5-spovG-DS-srfA-RC all have obvious bands near 33, indicating that DPEase in the recombinant strains can be successfully expressed.
Example 3: specific enzyme activity of recombinant enzyme under different pH conditions
The method comprises the following specific steps:
(1) respectively preparing phosphate buffer solutions with pH of 6.5, pH of 7.0 and pH of 8.5;
(2) respectively adding D-fructose into the phosphate buffer solution obtained in the step (1) to respectively obtain D-fructose solutions with the concentration of 300 g/L;
(3) to the D-fructose solution obtained in step (2), 100. mu.L of a DS-RC-containing crude enzyme solution, a DS-containing crude enzyme solution, an RC-containing crude enzyme solution, and a DS-HpaII-RC-containing crude enzyme solution were added, respectively. According to the method for measuring the enzyme activity of the crude enzyme solution, the specific enzyme activities of different DPEase crude enzyme solutions under different pH conditions are measured, the single enzyme expression and the coexpression of the DSDPEase and the RCDPEase are compared in the experiment, and the results are shown in Table 3. Note: the crude enzyme solution is prepared by crushing the same cells at the same concentration.
Table 3: specific enzyme activity (U/mL) of crude enzyme liquid of recombinant bacteria expressed by single enzyme and double enzymes in phosphate buffer solutions with different pH values
pH 6.5 7.0 8.5
B.subtilis 168/pMA5-DS 17.22 17.43 18.7
B.subtilis 168/pMA5-RC 16.71 16.6 17.23
B.subtilis 168/pMA5-DS-RC 18.65 18.76 18.85
The specific enzyme activity of the recombinase is 18.65U/mL under the condition of pH 6.5.
Definition of enzyme activity: the amount of enzyme required to convert 1 micromole of D-fructose in 1 minute is one activity unit U.
Specific enzyme activity definition: crude enzyme solution per ml of bacterial solution/enzyme activity per ml of bacterial solution.
(3) Adding D-fructose into the phosphate buffer solution with the pH of 6.5 obtained in the step (1) to obtain a D-fructose solution with the concentration of 300 g/L; to the obtained D-fructose solution, 100. mu.L of a crude enzyme solution containing DS-P43-RC, a crude enzyme solution containing DS-srfA-RC, a crude enzyme solution containing pMA5-DS-spovG-RC, a crude enzyme solution containing P43-DS-srfA-RC, and a crude enzyme solution containing spovG-DS-srfA-RC were added, and the specific enzyme activities of the different DPEase crude enzyme solutions were measured at pH6.5 according to the crude enzyme solution enzyme activity measurement method, and the results are shown in Table 4. Note: the crude enzyme solution is prepared by crushing the same cells at the same concentration.
Table 4: enzyme activity of different recombinant bacteria crude enzyme liquid in phosphate buffer solution with pH of 6.5
Figure BDA0002936580250000091
Figure BDA0002936580250000101
Through promoter screening, the specific enzyme activity of the recombinase prepared by the recombinant strain B.subtilis 168/pMA5-spovG-DS-srfA-RC under the condition of pH6.5 is 228.5U/mL, and the catalytic efficiency is improved by 12-13 times compared with that of the recombinant strain B.subtilis 168/pMA5-DS and B.subtilis 168/pMA 5-RC.
Also, the experiment of the recombinant strain B.subtilis 168/pMA5-spovG-DS-srfA-RC in example 3 was repeated for 13 times, and the results are shown in Table 5; the enzyme activity after repeating the batch for 13 times is still more than 50 percent, and the problem of insufficient enzyme activity under the weak acid condition is solved.
Table 5: different batches balance conversion rate and residual enzyme activity
Figure BDA0002936580250000102
Example 4: preparation of D-psicose by recombinant bacteria
And D-psicose is synthesized by transforming D-fructose with different concentrations by using B.subtilis 168/pMA5-spovG-DS-srfA-RC recombinant strain.
The method comprises the following specific steps:
(1) the B.subtilis 168/pMA5-spovG-DS-srfA-RC recombinant strain prepared in example 2 was transferred to LB solid medium containing kanamycin for activation, and cultured in a biochemical incubator at 37 ℃ for 12 hours to obtain a single colony.
(2) The activated single colonies were picked up and cultured in 10mL of LB liquid medium containing 50. mu.g/mL of kanamycin for 12 hours, transferred to 500mL of Ulper Rich medium containing 50. mu.g/mL of kanamycin at an inoculum size of 2% (v/v), cultured at 220rpm and 37 ℃ for 24 hours, and the cells were collected using a high-speed refrigerated centrifuge.
(3) Respectively preparing 300g/L, 500g/L and 750g/L D-fructose solutions by adopting a phosphate buffer solution with the pH of 6.5, and dissolvingThe pH of the solution is 6.5, and the solution is placed in a 250mL triangular flask; d-fructose solutions with different concentrations are placed on a magnetic stirrer to be heated, the cells collected in the step (2) are added when the temperature is constant, and the concentration of the cells in each reaction system with concentration gradient is OD60015 ℃ at 60 ℃ and at a rotation speed of 200 rpm;
taking 1mL of reaction solution from different reaction systems every 10 minutes, immediately carrying out high-speed centrifugation at 14000r/min by a refrigerated centrifuge at 4 ℃, centrifuging for 3min, and separating cells to stop the reaction. The obtained supernatant was analyzed and the results are shown in table 6, the detection method is as follows: an Agilent 1260 high performance liquid chromatograph and a differential detector, wherein the detection temperature is 55 ℃; hi Plex Ca ion exchange column, mobile phase ultrapure water, flow rate of 0.4 mL/min; individual samples run for 40 min.
Table 6: concentration of D-psicose produced at different times and different substrate concentrations (g/L)
Figure BDA0002936580250000111
As previously described herein, under mildly acidic conditions, the release of melanin by the maillard reaction is prevented. From the data in table 6, it is clear that the equilibrium conversion using a fructose solution with a concentration of 500g/L and 750g/L is almost 33% under weak acid (pH 6.5). At a fructose concentration of 750g/L, the recombinant strain B.subtilis 168/pMA5-spovG-DS-srfA-RC produced 244.3g/L of D-psicose in 30 minutes with a conversion of 32.6%.
Example 5: the specific enzyme activity of the recombinant strain B.subtilis 168/pMA5-spovG-DS-srfA-RC at the fermentation tank level comprises the following specific steps:
(1) preparing a seed solution: the B.subtilis 168/pMA5-spovG-DS-srfA-RC strain prepared in example 2 was streaked on LB solid plate medium and cultured in a biochemical incubator at 37 ℃ for 12 hours. A single colony is picked up and transferred into 10mL LB liquid culture medium, and is cultured for 12H at 37 ℃ in a shaking table at 180rpm, then is transferred into 100mL seed culture medium (15 g/L of sucrose, 20g/L, Na2HPO 4.12H 2O 1g/L, Mn2+0.05mmol/L of yeast extract powder and 8g/L of sodium chloride) according to the inoculation amount of 4% (v/v), and is continuously placed into the shaking table at 37 ℃ and is cultured for 16H at 180rpm, and seed liquid is obtained.
(2) Inoculating the seed liquid obtained in the step (1) into a 5L bioreactor containing 2L of fermentation medium (the formula is the same as the seed liquid) at an inoculation amount of 4% (v/v) for fed-batch fermentation. The culture conditions of the fermentation tank are as follows: the temperature is 37 ℃; the rotating speed is coupled with DO, and the DO is controlled to be 30%; when the pH value is 7.0, the supplementary materials (sucrose 300g/L and yeast powder 70g/L) are acidic, and replace acid to be connected with an acid pump, namely when the pH value in the fermentation tank is more than 7.0, the acid pump automatically adds a proper amount of supplementary materials to restore the pH value to 7.0. Fermenting continuously for 60h, collecting samples with different fermentation time, and freezing for storage.
Results as shown in fig. 4, biomass increased rapidly within the first 6 h; the pH value is increased due to the exhaustion of the sucrose, the supplementary material (matched with an acid pump) starts to flow, and the thallus density is 2-3 OD600The speed of/h is increased, the density of the thalli is increased to 98.8U/L in 30h, the enzyme activity is 387782U/L, after 36h enters a stable period, the bacterial count is not increased, the nutrient substance is used for protein expression, and the enzyme activity is improved.
OD600The cell density of (A) was increased to 108.4 in 42 hours, and the enzyme activity was 480098U/L, as shown in Table 7.
This result is about 11-fold higher than the previous results regarding the activity of recombinant Gluconobacter expressing D-psicose 3-epimerase (see, specifically, Yang J, Tian C, Zhang T, Ren C, Zhu Y, et al (2019) Development of food-grade expression system for D-allose 3-expression with the aid of the enzyme expression of microorganism genes in Corynebacterium glutamicum and enzyme application in conversion of can monomers to D-allose. The specific enzyme activities are measured by catalyzing 300g/L D-fructose to synthesize D-psicose in phosphate buffer solution with the pH value of 6.5.
In addition, the promoter contained by the strain B.subtilis 168/pMA5-spovG-DS-srfA-RC and the strain B.subtilis 168/pMA5-spovG-DS-srfA-RC is constitutive, and an inducer is not needed in the fermentation process.
Table 7: subtilis 168/pMA5-spovG-DS-srfA-RC fermentation culture
Figure BDA0002936580250000121
Figure BDA0002936580250000131
Example 6: the browning reaction is weakened by the recombinant strain
The invention researches the influence of different pH (6.5-8.5) conditions on browning of a reaction solution when the reaction solution is reacted at 60 ℃ by crude enzyme solution and a whole-cell catalytic D-fructose to generate D-psicose.
The method comprises the following specific steps:
(1) respectively preparing phosphate buffer solutions with pH of 6.5, pH of 7.0 and pH of 8.5;
(2) respectively adding D-fructose into the phosphate buffer solution obtained in the step (1) to respectively obtain D-fructose solutions with the concentration of 300 g/L; the D-fructose solution is subpackaged into 10 tubes, each tube is 900 mu L, and empty controls, 6.5-DS, 6.5-RC, 6.5-DS-RC, 7.0-DS, 7.0-RC, 7.0-DS-RC, 8.5-DS, 8.5-RC and 8.5-DS-RC are respectively marked on the tube body.
(3) Crude enzyme solutions (OD, each prepared from B.subtilis 168/pMA5-DS, B.subtilis 168/pMA5-RC and B.subtilis 168/pMA5-DS-RC strains, respectively60060 whole cell disruption) was added to each tube of fructose solution dispensed in step (2), and the mixture was stored at 60 ℃ for 30 min.
The sugar solution reacts with amino groups in the protein, and the Maillard reaction releases melanin. The results of the studies reported that the absorbance of the sample solution at 420nm was proportional to the melanin concentration, as shown in Table 8.
Table 8: browning degree OD of different crude enzyme solutions under the same pH420
Figure BDA0002936580250000132
Note: OD420The magnitude of the value is influenced by a number of factors, with pH and temperature being the primary factors.
From example 3, the co-expressing strainsSubtilis 168/pMA5-DS-RC, the enzyme activity is higher, and the color change and OD of the reaction solution are changed along with the change of pH420The comparison result is shown in fig. 3, and the browning degree and the pH magnitude show positive correlation.
The key to solve the browning problem is to reduce the pH of the reaction solution, and it can be understood from example 4 that the enzymatic properties of the single-enzyme-expressed DPEase cannot meet the requirement. Therefore, the invention improves the enzyme activity of the whole cell under the weak acid condition and can effectively solve the problem.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> university of south of the Yangtze river
<120> a recombinant Bacillus subtilis expressing D-psicose-3-epimerase
<130> BAA201691A
<160> 8
<170> PatentIn version 3.3
<210> 1
<211> 289
<212> PRT
<213> Artificial sequence
<400> 1
Met Lys His Gly Ile Tyr Tyr Ala Tyr Trp Glu Lys Glu Trp Ala Ala
1 5 10 15
Asp Tyr Leu Tyr Tyr Val Glu Lys Val Ala Arg Leu Gly Phe Asp Leu
20 25 30
Leu Glu Ile Gly Ala Ala Pro Leu Pro Glu Tyr Ser Thr Asp Gln Ile
35 40 45
Lys Ala Leu Arg Asp Cys Ala Ser Gln Asn Gly Ile Gln Leu Thr Ala
50 55 60
Gly Tyr Gly Pro Thr Tyr Asp His Asn Met Gly Ser Ser Asp Ala Gly
65 70 75 80
Ile Arg Ala Gly Ala Leu Glu Trp Tyr Lys Arg Leu Phe Asp Val Met
85 90 95
Glu Gln Leu Asp Ile His Leu Ile Gly Gly Ala Leu Tyr Gly Tyr Trp
100 105 110
Pro Val Asp Phe Ser Asn Ile Asn Lys Glu Glu Asp Trp Lys Arg Ser
115 120 125
Val Glu Gly Met His Leu Leu Ala Pro Ile Ala Lys Glu His Asp Ile
130 135 140
Asn Leu Gly Met Glu Val Leu Asn Arg Phe Glu Ser His Ile Leu Asn
145 150 155 160
Thr Ala Glu Glu Gly Val Ala Phe Val Lys Glu Val Gly Gln Glu Asn
165 170 175
Val Lys Val Met Leu Asp Thr Phe His Met Asn Ile Glu Glu Glu Ser
180 185 190
Ile Gly Asp Ala Ile Arg Thr Ala Gly Asn Leu Leu Gly His Phe His
195 200 205
Thr Gly Glu Cys Asn Arg Met Val Pro Gly Lys Gly Arg Thr Pro Trp
210 215 220
Arg Glu Ile Gly Asn Ala Leu Arg Asp Ile Glu Tyr Asp Gly Thr Val
225 230 235 240
Val Met Glu Pro Phe Val Ser Met Gly Gly Gln Val Gly Arg Asp Ile
245 250 255
His Ile Trp Arg Asp Ile Ser Arg Gly Ala Ser Glu Ala Glu Leu Asp
260 265 270
Lys Asp Ala Lys Asn Ala Val Ala Phe Gln Lys Tyr Met Leu Asp Trp
275 280 285
Lys
<210> 2
<211> 293
<212> PRT
<213> Artificial sequence
<400> 2
Met Lys His Gly Ile Tyr Tyr Ala Tyr Trp Glu Gln Glu Trp Glu Ala
1 5 10 15
Asp Tyr Lys Tyr Tyr Ile Glu Lys Val Ala Lys Leu Gly Phe Asp Ile
20 25 30
Leu Glu Ile Ala Ala Ser Pro Leu Pro Phe Tyr Ser Asp Ile Gln Ile
35 40 45
Asn Glu Leu Lys Ala Cys Ala His Gly Asn Gly Ile Thr Leu Thr Val
50 55 60
Gly His Gly Pro Ser Ala Glu Gln Asn Leu Ser Ser Pro Asp Pro Asp
65 70 75 80
Ile Arg Lys Asn Ala Lys Ala Phe Tyr Thr Asp Leu Leu Lys Arg Leu
85 90 95
Tyr Lys Leu Asp Val His Leu Ile Gly Gly Ala Leu Tyr Ser Tyr Trp
100 105 110
Pro Ile Asp Tyr Thr Lys Thr Ile Asp Lys Lys Gly Asp Trp Glu Arg
115 120 125
Ser Val Glu Ser Val Arg Glu Val Ala Lys Val Ala Glu Ala Cys Gly
130 135 140
Val Asp Phe Cys Leu Glu Val Leu Asn Arg Phe Glu Asn Tyr Leu Ile
145 150 155 160
Asn Thr Ala Gln Glu Gly Val Asp Phe Val Lys Gln Val Asp His Asn
165 170 175
Asn Val Lys Val Met Leu Asp Thr Phe His Met Asn Ile Glu Glu Asp
180 185 190
Ser Ile Gly Gly Ala Ile Arg Thr Ala Gly Ser Tyr Leu Gly His Leu
195 200 205
His Thr Gly Glu Cys Asn Arg Lys Val Pro Gly Arg Gly Arg Ile Pro
210 215 220
Trp Val Glu Ile Gly Glu Ala Leu Ala Asp Ile Gly Tyr Asn Gly Ser
225 230 235 240
Val Val Met Glu Pro Phe Val Arg Met Gly Gly Thr Val Gly Ser Asn
245 250 255
Ile Lys Val Trp Arg Asp Ile Ser Asn Gly Ala Asp Glu Lys Met Leu
260 265 270
Asp Arg Glu Ala Gln Ala Ala Leu Asp Phe Ser Arg Tyr Val Leu Glu
275 280 285
Cys His Lys His Ser
290
<210> 3
<211> 269
<212> DNA
<213> Artificial sequence
<400> 3
ttttgagtga tcttctcaaa aaatactacc tgtcccttgc tgatttttaa acgagcacga 60
gagcaaaacc cccctttgct gaggtggcag agggcaggtt tttttgtttc ttttttctcg 120
taaaaaaaag aaaggtctta aaggttttat ggttttggtc ggcactgccg acagcctcgc 180
agagcacaca ctttatgaat ataaagtata gtgtgttata ctttacttgg aagtggttgc 240
cggaaagagc gaaaatgcct cacatttgt 269
<210> 4
<211> 291
<212> DNA
<213> Artificial sequence
<400> 4
ggaattctga taggtggtat gttttcgctt gaacttttaa atacagccat tgaacatacg 60
gttgatttaa taactgacaa acatcaccct cttgctaaag cggccaagga cgctgccgcc 120
ggggctgttt gcgtttttgc cgtgatttcg tgtatcattg gtttacttat ttttttgcca 180
aagctgtaat ggctgaaaat tcttacattt attttacatt tttagaaatg ggcgtgaaaa 240
aaagcgcgcg attatgtaaa atataaagtg atagcggtac cattataggt a 291
<210> 5
<211> 591
<212> DNA
<213> Artificial sequence
<400> 5
tatcgacaaa aatgtcatga aagaatcgtt gtaagacgct cttcgcaagg gtgtcttttt 60
ttgccttttt ttcggttttt gcgcggtaca catagtcatg taaagattgt aaattgcatt 120
cagcaataaa aaaagattga acgcagcagt ttggtttaaa aatttttatt tttctgtaaa 180
taatgtttag tggaaatgat tgcggcatcc cgcaaaaaat attgctgtaa ataaactgga 240
atctttcggc atcccgcatg aaacttttca cccatttttc ggtgataaaa acattttttt 300
catttaaact gaacggtaga aagataaaaa atattgaaaa caatgaataa atagccaaaa 360
ttggtttctt attagggtgg ggtcttgcgg tctttatccg cttatgttaa acgccgcaat 420
gctgactgac ggcagcctgc tttaatagcg gccatctgtt ttttgattgg aagcactgct 480
ttttaagtgt agtactttgg gctatttcgg ctgttagttc ataagaatta aaagctgata 540
tggataagaa agagaaaatg cgttgcacat gttcactgct tataaagatt a 591
<210> 6
<211> 300
<212> DNA
<213> Artificial sequence
<400> 6
tgcggaagta aacgaagtgt acggacaata ttttgacact cacaaaccgg cgagatcttg 60
tgttgaagtc gcgagactcc cgaaggatgc gttagtcgag atcgaagtta ttgcactggt 120
gaaataataa gaaaagtgat tctgggagag ccgggatcac ttttttattt accttatgcc 180
cgaaatgaaa gctttatgac ctaattgtgt aactatatcc tattttttca aaaaatattt 240
taaaaacgag caggatttca gaaaaaatcg tggaattgat acactaatgc ttttatatag 300
<210> 7
<211> 870
<212> DNA
<213> Artificial sequence
<400> 7
atgaaacacg gaatttacta tgcctattgg gaaaaagaat gggctgcgga ctacttgtat 60
tatgttgaaa aagtcgcacg tttaggcttt gatcttctgg aaatcggtgc tgcaccatta 120
ccggaatata gcacagatca gattaaagca ctccgcgatt gtgcctctca gaacggaatt 180
cagttgactg ccggatatgg tcctacttac gaccataaca tgggctcttc agatgcgggt 240
attcgcgccg gtgcattaga atggtacaaa cgtctctttg atgttatgga acagcttgat 300
atccatttga tcggcggcgc tctctatgga tattggccgg tagactttag caacatcaac 360
aaagaagagg attggaagcg aagcgttgaa ggaatgcatc ttcttgctcc tatcgccaaa 420
gaacatgata tcaatctcgg aatggaagta ctgaaccgct ttgaatccca cattttaaat 480
actgccgaag aaggtgttgc cttcgtaaaa gaggtcggac aggaaaatgt gaaagtaatg 540
ttagacacct tccatatgaa catcgaggag gaaagtatcg gtgatgcaat ccgcactgcc 600
ggcaatcttc tcggtcactt ccacaccggt gaatgtaacc gtatggttcc gggaaaagga 660
cgcacccctt ggagagagat cggaaatgct ctccgcgata ttgaatacga tggaactgtt 720
gtcatggaac catttgtcag catgggcggt caggttggtc gagatattca tatctggcgc 780
gacatcagcc gcggtgcatc tgaagcagaa ttagataaag acgcgaaaaa tgcagttgca 840
ttccagaaat atatgttgga ttggaaataa 870
<210> 8
<211> 882
<212> DNA
<213> Artificial sequence
<400> 8
atgaaacatg gtatatacta cgcatattgg gaacaagaat gggaagctga ttacaaatac 60
tatattgaga aggttgcaaa gcttggtttt gatattctag agattgcagc ttcaccgcta 120
cctttttaca gtgacattca gattaatgag ctcaaggcat gtgcccatgg caatggaatt 180
acacttacgg taggccatgg gcctagtgca gaacaaaacc tgtcttctcc cgaccccgat 240
attcgcaaaa atgctaaagc tttttatacc gatttactca aacgacttta caagctggat 300
gtacatttga taggtggggc tttatattct tattggccga tagattacac aaagacaatt 360
gataaaaaag gcgattggga acgcagcgtt gaaagtgttc gagaagttgc taaggtggcc 420
gaagcctgtg gagtggattt ctgcctagag gttcttaata gatttgagaa ttatttaatt 480
aacacagcac aagagggtgt agattttgta aaacaggttg accataacaa tgtaaaggta 540
atgcttgata ccttccatat gaatattgag gaagatagta tcggaggtgc aatcaggact 600
gcgggctctt acttgggaca tttacacact ggcgaatgta atcgtaaagt tcccggcaga 660
ggaagaattc catgggtaga aattggtgag gctcttgctg acataggtta taacggtagt 720
gttgttatgg aaccttttgt tagaatgggc ggaactgtcg gatctaatat taaggtttgg 780
cgtgacatta gtaacggtgc agatgagaaa atgctggata gagaagcaca ggccgcactt 840
gatttctcca gatatgtatt agaatgtcat aaacactcct ga 882

Claims (10)

1. A recombinant Bacillus subtilis which expresses a D-psicose 3-epimerase derived from Dorea sp.CAG317 and a D-psicose 3-epimerase derived from Clostridium cellulolyticum H10.
2. The recombinant Bacillus subtilis of claim 1 wherein Bacillus subtilis 168 is the expression host.
3. The recombinant Bacillus subtilis of claim 1 or claim 2 wherein the expression vector is pMA 5.
4. The recombinant Bacillus subtilis of any one of claims 1 to 3, wherein expression of D-psicose 3-epimerase is enhanced by one or more of the promoters HpaII, P43, srfA, spovG.
5. The recombinant Bacillus subtilis of any one of claims 1 to 4, wherein the amino acid sequence of D-psicose 3-epimerase derived from Dorea sp.CAG317 is shown in SEQ ID NO 1, and the amino acid sequence of D-psicose 3-epimerase derived from Clostridium cellulolyticum H10 is shown in SEQ ID NO 2.
6. A method for constructing the recombinant Bacillus subtilis of any one of claims 1 to 5, comprising the steps of:
(1) constructing a recombinant plasmid: respectively carrying out enzyme digestion on D-psicose 3-epimerase DS derived from Dorea sp.CAG317 and D-psicose 3-epimerase RC derived from Clostridium cellulolyticum H10 and a pMA5 plasmid, and then connecting to obtain a recombinant plasmid pMA 5-DS-RC;
(2) constructing recombinant bacillus subtilis: and (2) transforming the recombinant plasmid pMA5-DS-RC obtained in the step (1) into the bacillus subtilis 168 to obtain the recombinant bacillus subtilis.
7. A method for reducing browning reaction, characterized in that the recombinant Bacillus subtilis according to any one of claims 1 to 5 is added to a reaction system containing D-fructose to carry out the reaction.
8. The method of claim 7, wherein the OD of the recombinant Bacillus subtilis is added600At least 15.
9. The method of claim 7 or 8, wherein the reaction conditions are: the pH value is 6.0-7.0, and the temperature is 55-65 ℃.
10. Use of the recombinant bacillus subtilis of any one of claims 1 to 5 for reducing browning reactions during food processing, or for preparing a high-sweetness, low-calorie food.
CN202110163604.8A 2021-02-05 2021-02-05 Recombinant bacillus subtilis for expressing D-psicose-3-epimerase Active CN112695006B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110163604.8A CN112695006B (en) 2021-02-05 2021-02-05 Recombinant bacillus subtilis for expressing D-psicose-3-epimerase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110163604.8A CN112695006B (en) 2021-02-05 2021-02-05 Recombinant bacillus subtilis for expressing D-psicose-3-epimerase

Publications (2)

Publication Number Publication Date
CN112695006A true CN112695006A (en) 2021-04-23
CN112695006B CN112695006B (en) 2023-07-18

Family

ID=75516655

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110163604.8A Active CN112695006B (en) 2021-02-05 2021-02-05 Recombinant bacillus subtilis for expressing D-psicose-3-epimerase

Country Status (1)

Country Link
CN (1) CN112695006B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111019928A (en) * 2019-12-11 2020-04-17 吉林中粮生化有限公司 Coding gene, vector and recombinant cell of D-psicose 3-epimerase and application thereof
CN114350699A (en) * 2021-12-02 2022-04-15 江南大学 Strain for producing D-psicose 3-epimerase and application thereof
CN114703170A (en) * 2022-04-26 2022-07-05 浙江大学 Thermostable mutant of D-psicose 3-epimerase and high-throughput screening method thereof
CN116064619A (en) * 2022-09-26 2023-05-05 无锡特殊食品与营养健康研究院有限公司 Bacillus licheniformis cell capable of being stably and repeatedly used for D-psicose conversion synthesis
CN116286770A (en) * 2023-02-23 2023-06-23 山东健德生物医药有限公司 D-psicose-3-epimerase from clostridium and application thereof
CN116333157A (en) * 2022-07-20 2023-06-27 无锡佰翱得生物科学股份有限公司 Modified D-psicose3-epimerase and application thereof
WO2023114814A3 (en) * 2021-12-14 2023-07-27 Danisco Us Inc. Compositions and methods for producing allulose
CN116536235A (en) * 2023-05-24 2023-08-04 江南大学 Bacillus subtilis for efficiently secreting and expressing osteopontin as well as construction method and application thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105602879A (en) * 2016-01-26 2016-05-25 中国科学院天津工业生物技术研究所 Genetic engineering strain capable of effectively secreting D-psicose 3-epimerase and construction method and application thereof
CN105637089A (en) * 2013-09-03 2016-06-01 罗盖特兄弟公司 Improved variant of d-psicose 3-epimerase and uses thereof
CN107723307A (en) * 2017-10-09 2018-02-23 中国科学院天津工业生物技术研究所 A kind of method and its application for efficiently preparing the epimerase of D psicoses 3
CN108018278A (en) * 2018-01-22 2018-05-11 江南大学 The D-Psicose 3- epimerism enzyme mutants that a kind of catalytic efficiency improves
CN108034648A (en) * 2018-01-22 2018-05-15 江南大学 The D-Psicose 3- epimerism enzyme mutants that a kind of heat endurance improves
CN108588149A (en) * 2017-10-29 2018-09-28 中国科学院天津工业生物技术研究所 A kind of algol syrup and preparation method thereof
WO2019086708A1 (en) * 2017-11-06 2019-05-09 Roquette Freres A genetically modified bacillus subtilis strain, optimized vectors, and uses thereof
CN112080453A (en) * 2020-08-28 2020-12-15 天津科技大学 Genetic engineering bacterium for synthesizing D-psicose and construction method and application thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105637089A (en) * 2013-09-03 2016-06-01 罗盖特兄弟公司 Improved variant of d-psicose 3-epimerase and uses thereof
CN105602879A (en) * 2016-01-26 2016-05-25 中国科学院天津工业生物技术研究所 Genetic engineering strain capable of effectively secreting D-psicose 3-epimerase and construction method and application thereof
CN107723307A (en) * 2017-10-09 2018-02-23 中国科学院天津工业生物技术研究所 A kind of method and its application for efficiently preparing the epimerase of D psicoses 3
CN108588149A (en) * 2017-10-29 2018-09-28 中国科学院天津工业生物技术研究所 A kind of algol syrup and preparation method thereof
WO2019086708A1 (en) * 2017-11-06 2019-05-09 Roquette Freres A genetically modified bacillus subtilis strain, optimized vectors, and uses thereof
CN108018278A (en) * 2018-01-22 2018-05-11 江南大学 The D-Psicose 3- epimerism enzyme mutants that a kind of catalytic efficiency improves
CN108034648A (en) * 2018-01-22 2018-05-15 江南大学 The D-Psicose 3- epimerism enzyme mutants that a kind of heat endurance improves
CN112080453A (en) * 2020-08-28 2020-12-15 天津科技大学 Genetic engineering bacterium for synthesizing D-psicose and construction method and application thereof

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
HONGBEI WEI等: "Expression of D-psicose-3-epimerase from Clostridium bolteae and Dorea sp. And whole-cell production of D-psicose in Bacillus subtilis", 《ANNALS OF MICROBIOLOGY》 *
HONGBEI WEI等: "Expression of D-psicose-3-epimerase from Clostridium bolteae and Dorea sp. And whole-cell production of D-psicose in Bacillus subtilis", 《ANNALS OF MICROBIOLOGY》, vol. 70, 2 March 2020 (2020-03-02) *
LINGQIA SU等: "Highly efcient production of Clostridium cellulolyticum H10 d-psicose 3-epimerase in Bacillus subtilis and use of these cells to produce d-psicose", 《MICROB CELL FACT》 *
LINGQIA SU等: "Highly efcient production of Clostridium cellulolyticum H10 d-psicose 3-epimerase in Bacillus subtilis and use of these cells to produce d-psicose", 《MICROB CELL FACT》, 28 November 2018 (2018-11-28), pages 1 - 10 *
WENLI ZHANG等: "Characterization of a d-psicose 3-epimerase from Dorea sp. CAG317 with an acidic pH optimum and a high specific activity", 《JOURNAL OF MOLECULAR CATALYSIS B: ENZYMATIC》 *
WENLI ZHANG等: "Characterization of a d-psicose 3-epimerase from Dorea sp. CAG317 with an acidic pH optimum and a high specific activity", 《JOURNAL OF MOLECULAR CATALYSIS B: ENZYMATIC》, vol. 120, 3 July 2015 (2015-07-03), pages 68 - 74, XP002785785 *
孙帆等: "D-阿洛酮糖 3-差向异构酶在枯草芽孢杆菌中的高效表达及固定化细胞研究", 《中国生物工程杂志》 *
孙帆等: "D-阿洛酮糖 3-差向异构酶在枯草芽孢杆菌中的高效表达及固定化细胞研究", 《中国生物工程杂志》, vol. 38, no. 7, 31 December 2018 (2018-12-31), pages 83 - 88 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111019928A (en) * 2019-12-11 2020-04-17 吉林中粮生化有限公司 Coding gene, vector and recombinant cell of D-psicose 3-epimerase and application thereof
CN114350699A (en) * 2021-12-02 2022-04-15 江南大学 Strain for producing D-psicose 3-epimerase and application thereof
JP7489134B2 (en) 2021-12-02 2024-05-23 江南大学 D-psicose 3-epimerase producing strain and use thereof
US11970723B2 (en) 2021-12-02 2024-04-30 Jiangnan University Strain producing D-allulose 3-epimerase and application thereof
WO2023097975A1 (en) * 2021-12-02 2023-06-08 江南大学 Strain capable of producing d-allulose-3-epimerase and use thereof
CN114350699B (en) * 2021-12-02 2024-03-26 江南大学 Strain for producing D-psicose 3-epimerase and application thereof
WO2023114814A3 (en) * 2021-12-14 2023-07-27 Danisco Us Inc. Compositions and methods for producing allulose
CN114703170B (en) * 2022-04-26 2023-11-28 浙江大学 Thermostable mutant of D-psicose 3-epimerase and high-throughput screening method thereof
CN114703170A (en) * 2022-04-26 2022-07-05 浙江大学 Thermostable mutant of D-psicose 3-epimerase and high-throughput screening method thereof
CN116333157B (en) * 2022-07-20 2023-10-03 无锡佰翱得生物科学股份有限公司 Modified D-psicose3-epimerase and application thereof
CN116333157A (en) * 2022-07-20 2023-06-27 无锡佰翱得生物科学股份有限公司 Modified D-psicose3-epimerase and application thereof
CN116064619B (en) * 2022-09-26 2023-11-21 无锡特殊食品与营养健康研究院有限公司 Bacillus licheniformis cell capable of being stably and repeatedly used for D-psicose conversion synthesis
WO2024067086A1 (en) * 2022-09-26 2024-04-04 无锡特殊食品与营养健康研究院有限公司 Bacillus licheniformis cell capable of being stably and repeatedly used for conversion and synthesis of d-allulose
CN116064619A (en) * 2022-09-26 2023-05-05 无锡特殊食品与营养健康研究院有限公司 Bacillus licheniformis cell capable of being stably and repeatedly used for D-psicose conversion synthesis
CN116286770B (en) * 2023-02-23 2023-10-17 山东健德生物医药有限公司 D-psicose-3-epimerase from clostridium and application thereof
CN116286770A (en) * 2023-02-23 2023-06-23 山东健德生物医药有限公司 D-psicose-3-epimerase from clostridium and application thereof
CN116536235A (en) * 2023-05-24 2023-08-04 江南大学 Bacillus subtilis for efficiently secreting and expressing osteopontin as well as construction method and application thereof

Also Published As

Publication number Publication date
CN112695006B (en) 2023-07-18

Similar Documents

Publication Publication Date Title
CN112695006B (en) Recombinant bacillus subtilis for expressing D-psicose-3-epimerase
CN111712570B (en) Engineering strain for producing psicose and derivatives thereof, construction method and application thereof
EP2470668B1 (en) Immobilization of psicose-epimerase and a method of producing d-psicose using the same
EP2990483B1 (en) Psicose epimerase mutant and method for preparing psicose by using same
Aarnikunnas et al. The mannitol dehydrogenase gene (mdh) from Leuconostoc mesenteroides is distinct from other known bacterial mdh genes
CN112831488B (en) Glutamic acid decarboxylase and gamma-aminobutyric acid high-yield strain
CN111690624A (en) Method for synthesizing 2-O-alpha-D-glycerol glucoside by using microorganisms
CN113234699A (en) Alpha-1, 2-fucosyltransferase and application thereof
CN112725319A (en) Alginate lyase FaAly7 with polyG substrate specificity and application thereof
CN112175918A (en) 7 alpha-hydroxysteroid dehydrogenase mutant St-2-2 delta C10 and application thereof
CN110438112B (en) Mutant of D-psicose-3-epimerase and application thereof
JP2023551624A (en) D-psicose 3-epimerase producing strain and its use
CN113801240B (en) D-psicose-3-epimerase activity aggregate and preparation method and application thereof
CN113106112B (en) Genetically engineered bacterium for heterologously expressing xanthan endonuclease and application thereof
CN112980906B (en) Enzyme composition for preparing beta-nicotinamide mononucleotide and application thereof
WO2024002131A1 (en) Engineered microorganism for efficiently expressing d-psicose 3-epimerase and use thereof
CN109628476B (en) Method for producing 4-hydroxyisoleucine by using whole cell transformation
CN111154748A (en) Acetohydroxy acid synthase mutant for improving L-isoleucine synthesis purity
CN115896206A (en) Synthesis method of D-mannose
CN113005132B (en) D-psicose-3-epimerase gene and application method thereof
CN113151232B (en) 1-aminocyclopropane-1-carboxylic acid synthetase of lycoris aurea, and coding gene and application thereof
CN111549045B (en) Vitamin K improvement by utilizing recombinant bacillus natto 2 Method for producing yield
CN115011622A (en) Screening method and application of D-psicose 3-epimerase mutant
CN113736803A (en) Recombinant bacillus subtilis for expressing acetaldehyde dehydrogenase and application thereof
CN116323937A (en) Method for producing ketose using novel ketose-3-epimerase

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant